ATLANTA--(BUSINESS WIRE)--Sciele Pharma, Inc. (NASDAQ:SCRX) today announced the launch of Prenate DHA, a prescription multivitamin nutritional supplement with essential minerals, Omega-3 fatty acids/DHA and Metafolin, indicated for use in improving the nutritional status of women throughout pregnancy and in the postnatal period for both lactating and non-lactating mothers. Prenate DHA can also be beneficial in improving the nutritional status of women prior to conceiving.
